Patents
US 10350229 B2: Use of lactulose in the treatment of autism
- Granted
- 2019-07-16
- Filed
- 2016-04-04 application 15089842
- Type
- Utility · 13 claims
- Elsewhere
- Google Patents ↗ · USPTO patent document ↗ · USPTO Patent Center record ↗
Abstract
A treatment for autism in which an effective amount of lactulose is administered in order to bind excess ammonia in the gastrointestinal tract, the bloodstream, and the nervous system in order to prevent or reverse ammonia poisoning caused by the administration of certain antibiotics. Lactulose molecules in the colon are fermented by certain bacteria. The fermentation process lowers the colonic pH, and ammonia, in the form of ammonium ions, is used by the bacteria for amino acid and protein synthesis. This lowers the serum ammonia levels and reduces neurotoxicity.
Source: PVGPATDIS, file of 2026-04-10 (ipg190716.xml).
Assignees
| Assignee | Type | Place | Also on furp.org | Source |
|---|---|---|---|---|
| CUREMARK, LLC 55 patents | US company or organization | Rye, NY | CUREMARK, LLC State business registration EXACT high confidence: identical full name and state CUREMARK LLC Form D issuer EXACT high confidence: identical full name and state | PVGPATDIS, file of 2026-04-10 |
Inventors
| Inventor | Place | Patents | Person page | Source |
|---|---|---|---|---|
| Joan M. Fallon | Bronxville, NY | 61 | PVGPATDIS, file of 2026-04-10 | |
| Richard Feltenstein | New Rochelle, NY | 4 | PVGPATDIS, file of 2026-04-10 |
CPC categories
| Subclass | Category | First group | Source |
|---|---|---|---|
| A61K | Preparations for medical, dental or toiletry purposes | A61K31/7016 | PVGPATDIS, file of 2026-04-10 |
| A61P | Specific therapeutic activity of chemical compounds or medicinal preparations | A61P1/00 | PVGPATDIS, file of 2026-04-10 |
Cooperative Patent Classification, as currently assigned (one row per subclass).
Assignments and security interests
| Recorded | What | From | To | Reel/frame | Source |
|---|---|---|---|---|---|
| 2017-01-18 | Correction Corrective assignment to correct the assignee name, have comma previously recorded at reel: 038194 frame: 0680. assignor(s) hereby confirms the assignment. | FALLON, JOAN M. signed 2013-12-20 FELTENSTEIN, RICHARD signed 2013-12-20 | CUREMARK, LLC RYE, NY | 41440/197 | ECORSEXC, file of 2026-09-25 |
| 2016-04-05 | Assignment Assignment of assignor's interest | FALLON, JOAN M. signed 2013-12-20 FELTENSTEIN, RICHARD signed 2013-12-20 | CUREMARK LLC RYE, NY | 38194/680 | ECORSEXC, file of 2026-09-25 |
Documents recorded with the USPTO Assignment Recordation Branch that list this patent. A security interest is a lender’s claim on the patent as collateral; a release ends it.
USPTO bulk data: PatentsView granted patents, disambiguated (PVGPATDIS) for patents, assignees, inventors, places and CPC categories; the USPTO Patent Assignment Dataset (ECORSEXC) for assignments and security interests. Patents filed in the last 20 years. No claims or full text. Links to other records are by name (and state): EXACT means the identical full name and state; FUZZY means a looser name match, with the confidence shown.